Skip to content
MarketScale
‹ Back to IndustriesSciences

Solving Thermal Limitations for Emergency and First-Response UAVs

Thermal imaging technology for drones is vital for emergency services like firefighting and search and rescue operations. Despite its effectiveness, challenges such as regulatory issues, flight time, and payload power consumption remain. The integration of advanced thermal modules like FLIR's Hadron could broaden the use of high-resolution thermal technology in various applications.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Daniel Litwin · Commercial DroneCommercial Drone AllianceCommercial Drone OperationsDaniel Litwin Video
Share
Solving Thermal Limitations for Emergency and First-Response UAVs

Key takeaways

01

Thermal imaging technology from drones is critical in difficult terrains for emergency services.

02

Current challenges include regulatory compliance, flight time limitations, and payload efficiency.

03

Advanced thermal modules can expand the application of high-resolution thermal technology.

Daniel Litwin of The Voice of B2B hosted Randall Warnas, Global sUAS Segment Leader with FLIR, to discuss drone thermal payload technology. The pair looked at the use of thermal imaging technology today, its limitations, and the future of the technology across a variety of applications.

Warnas explained that thermal imaging technology has become a vital tool for firefighting, search and rescue, and law enforcement. The ability to gather thermal information from an unmanned aerial perspective is critical when terrain obstacles prevent vehicles and personnel from entering an area. The thermal technology itself enables the expedited gathering of information, day or night, that could prove instrumental in the saving of lives.

Thermal drone technology has an ever growing list of success stories, but there are limitations and areas of improvement. “I think the limitations behind drones right now is going to be regulatory, but it’s also flight time,” Warnas said. He continued by stating the challenge was to “shrink down size, weight, and power consumption of payloads.”

Another limitation is the thermal imaging resolution. Many handheld temperature reading devices have an accuracy within 2 degrees. Measuring temperature from a distance in an aerial setting presents a sizable challenge. Even so, drone thermal readings can be accurate to +/- 5 degrees, which is still suitable for the majority of applications.

Litwin and Warnas also discussed FLIR’s Hadron module, a thermal imaging technology meant for OEM integration. The idea is to enable a broader number of aerial platforms to use high resolution thermal technology to greatly expand the applications for this powerful innovation.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

Daniel Litwin
Daniel LitwinEditor, B2B Media, MarketScale

Daniel Litwin is a journalist of multiple disciplines focused on finding and telling engaging stories for B2B communities. He has interviewed executives from Fortune 500 companies including Honeywell, Microsoft, John Deere, and Chipotle, and leads editorial direction at MarketScale. Litwin hosts weekly shows and podcasts while helping develop new content approaches across the MarketScale platform. He holds a B.J. in Radio/Television Reporting/Anchoring and a B.A. in Spanish from the University of Missouri-Columbia.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

Daniel Litwin
Daniel Litwin

Host, The Voice of B2B at MarketScale

MarketScale

Daniel Litwin is a media host for MarketScale's The Voice of B2B platform. He focuses on creating content around various industries and technological advancements. Litwin is experienced in facilitating discussions with industry experts to explore emerging trends and technologies.

RW
Randall Warnas

Global sUAS Segment Leader

FLIR

Randall Warnas is the Global sUAS Segment Leader at FLIR. He specializes in drone thermal payload technology and its diverse applications. Warnas discusses the impact of thermal imaging technology for emergency services and its future advancements.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512